These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 11855699)
1. State of the art in cholesterol management: targeting multiple pathways. Turley SD Am J Manag Care; 2002 Feb; 8(2 Suppl):S29-32; discussion S45-7. PubMed ID: 11855699 [TBL] [Abstract][Full Text] [Related]
2. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Daskalopoulou SS; Mikhailidis DP Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035 [TBL] [Abstract][Full Text] [Related]
3. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men. Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E; J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343 [TBL] [Abstract][Full Text] [Related]
4. [New treatment option for decreasing blood cholesterol level--clinical significance of inhibition of both, cholesterol absorption and synthesis]. Paragh G; Márk L; Czine Z Orv Hetil; 2004 Apr; 145(15):805-11. PubMed ID: 15188635 [TBL] [Abstract][Full Text] [Related]
5. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques. Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082 [TBL] [Abstract][Full Text] [Related]
6. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. Hou R; Goldberg AC Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513 [TBL] [Abstract][Full Text] [Related]
8. Management of dyslipidemia in the high-risk patient. Stein EA Am Heart J; 2002 Dec; 144(6 Suppl):S43-50. PubMed ID: 12486415 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial. Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317 [TBL] [Abstract][Full Text] [Related]
10. Future outlook: changing perspectives on best practice. Rader DJ Am J Manag Care; 2002 Feb; 8(2 Suppl):S40-4; discussion S45-7. PubMed ID: 11855702 [TBL] [Abstract][Full Text] [Related]
11. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin. Gazi IF; Daskalopoulou SS; Nair DR; Mikhailidis DP Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154 [TBL] [Abstract][Full Text] [Related]
14. Clinical use of ezetimibe. Cheng AY; Leiter LA Can J Clin Pharmacol; 2003; 10 Suppl A():21A-5A. PubMed ID: 14571302 [TBL] [Abstract][Full Text] [Related]
15. Cholesterol absorption inhibition: a strategy for cholesterol-lowering therapy. Miettinen TA Int J Clin Pract; 2001 Dec; 55(10):710-6. PubMed ID: 11777299 [TBL] [Abstract][Full Text] [Related]
16. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects. Gylling H; Miettinen TA Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):19-23. PubMed ID: 12125225 [TBL] [Abstract][Full Text] [Related]
17. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia. Bays HE; Davidson M; Jones MR; Abby SL Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026 [TBL] [Abstract][Full Text] [Related]
18. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E; Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231 [TBL] [Abstract][Full Text] [Related]
19. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study. Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245 [TBL] [Abstract][Full Text] [Related]
20. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy. Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]